Stephen Mitchener serves as Executive at Karyopharm Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Stephen Mitchener has executed 7 insider transactions totaling $27.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 1, 2023 involved selling 6,357 shares valued at $19.3K.
Stephen Mitchener currently holds 128,313 shares of Karyopharm Therapeutics Inc. (KPTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen Mitchener has been a net seller of KPTI stock. They have purchased $0 and sold $27.5K worth of shares.
Stephen Mitchener's most recent insider trade was on Mar 1, 2023, when they sold 6,357 shares at $3.03 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 31, 2022 | KPTI | $0 | Award | 20,000 | $N/A | Discretionary |
| Feb 28, 2022 | KPTI | $0 | Award | 47,250 | $N/A | Discretionary |
| Dec 2, 2021 | KPTI | $3.3K | Sale | 499 | $6.69 | Discretionary |
| Jun 2, 2021 | KPTI | $4.9K | Sale | 528 | $9.29 | Discretionary |
| May 30, 2021 | KPTI | $0 | Option Exercise | 1,500 | $N/A | Discretionary |